NASDAQ:CARA
Cara Therapeutics Stock News
$0.684
-0.0157 (-2.24%)
At Close: Apr 26, 2024
First Trust Advisors LP Buys New Stake in Cara Therapeutics Inc (NASDAQ:CARA)
11:16am, Wednesday, 04'th Mar 2020
First Trust Advisors LP bought a new stake in Cara Therapeutics Inc (NASDAQ:CARA) during the fourth quarter, according to its most recent filing with the SEC. The firm bought 17,476 shares of the biop
Your first trade for Tuesday, March 3
03:13pm, Tuesday, 03'rd Mar 2020
The "Fast Money" traders share their first moves for the market open.
Research Analysts Offer Predictions for Cara Therapeutics Inc's Q3 2020 Earnings (NASDAQ:CARA)
08:14am, Tuesday, 03'rd Mar 2020
Cara Therapeutics Inc (NASDAQ:CARA) – Stock analysts at Jefferies Financial Group issued their Q3 2020 earnings estimates for Cara Therapeutics in a research note issued on Friday, February 28th. Je
Cara Therapeutics (CARA) Gets a Buy Rating from H.C. Wainwright
12:13pm, Monday, 02'nd Mar 2020
In a report released today, Oren Livnat from H.C. Wainwright reiterated a Buy rating on Cara Therapeutics (CARA), with a price target of $30.00. The
Cara Therapeutics (CARA) Gets a Buy Rating from H.C. Wainwright
12:13pm, Monday, 02'nd Mar 2020
In a report released today, Oren Livnat from H.C. Wainwright reiterated a Buy rating on Cara Therapeutics (CARA – Research
Analysts Are Bullish on These Healthcare Stocks: Staar Surgical Company (STAA), Biohaven Pharmaceutical Holding Co (BHVN)
11:14am, Monday, 02'nd Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Staar Surgical Company (STAA), Biohaven Pharmaceutical
Analysts Are Bullish on These Healthcare Stocks: Staar Surgical Company (STAA), Biohaven Pharmaceutical Holding Co (BHVN)
11:14am, Monday, 02'nd Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Staar Surgical Company (
STAA
–
Research Report
), Biohaven Pharmaceutical Holding Co (
BHVN
–
Rese
Piper Sandler Weighs in on Cara Therapeutics Inc's FY2023 Earnings (NASDAQ:CARA)
09:32am, Monday, 02'nd Mar 2020
Cara Therapeutics Inc (NASDAQ:CARA) – Research analysts at Piper Sandler cut their FY2023 EPS estimates for Cara Therapeutics in a note issued to investors on Thursday, February 27th. Piper Sandler
Cara Therapeutics, Inc. Just Reported And Analysts Have Been Cutting Their Estimates
01:05pm, Saturday, 29'th Feb 2020
There's been a notable change in appetite for Cara Therapeutics, Inc. (NASDAQ:CARA) shares in the week since its...
Cara Therapeutics Inc (CARA) Q4 2019 Earnings Call Transcript
06:01pm, Friday, 28'th Feb 2020
CARA earnings call for the period ending December 31, 2019.
Cara Therapeutics: Scratching At Multiple Indications In 2020
05:54pm, Friday, 28'th Feb 2020
2020 is a big year for oral Korsuva. CARA took a big hit in late 2019 from oral phase 2 data. The second phase 3 readout for IV Korsuva, KALM-II, is set to repo
SWK Holdings Provides Portfolio Update Highlighting Recent Achievements
01:00pm, Friday, 28'th Feb 2020
SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, today provided an update on the progress and ach
The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
12:28pm, Friday, 28'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 27) Global Cord Blood Corp (NYSE: CO ) Cleveland BioLa
